NCT03254355

Brief Summary

Childbirth is a major risk factor for pelvic floor muscle (PFM) trauma. In one third of women, stretching of the PFM will result in an avulsion injury (i.e. disconnection of the muscle from its insertion points on the pubic symphysis). Recent advances in imaging have led to the discovery of this previously unknown major injury and further research now enables its diagnosis with readily available techniques. Avulsion injury has alarming consequences because it has been associated with a higher rate of urinary incontinence in the postpartum period as well as the long-term development of other major urogynecological conditions such as pelvic organ prolapse and anal incontinence. Women with avulsion not only suffer from severe symptoms with significant related impacts on physical activities, overall well-being and quality of life, but they also present a higher rate of surgical failures. Moreover, it is still unknown whether the most recommended first-line treatment for urinary incontinence -PFM physiotherapy- is effective in women with this major trauma. Until now, only a pilot study conducted by our team supports the rationale and the efficacy of physiotherapy for improving PFM function in women with avulsion, despite their major muscle injury. Primary objective: To evaluate the efficacy of physiotherapy for urinary incontinence in women with avulsion at 9-months after randomization compared to a waiting-list control group. Secondary objectives:

  1. 1.To compare physiotherapy to the control group after treatment and at 9-months after randomization in terms of: a) incontinence and prolapse (objective quantification, symptoms and related impact); b) PFM morphology and function; c) sexual function; d) self-efficacy; e) cost analysis; f) treatment satisfaction and impression of change.
  2. 2.To investigate the impact of the severity of the avulsion (i.e. unilateral or bilateral) on the response to physiotherapy treatment on the aforementioned outcomes.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
126

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Aug 2017

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

August 9, 2017

Completed
9 days until next milestone

First Posted

Study publicly available on registry

August 18, 2017

Completed
10 days until next milestone

Study Start

First participant enrolled

August 28, 2017

Completed
5.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 10, 2023

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

May 10, 2023

Completed
Last Updated

June 15, 2023

Status Verified

June 1, 2023

Enrollment Period

5.7 years

First QC Date

August 9, 2017

Last Update Submit

June 12, 2023

Conditions

Keywords

avulsion injuryurinary incontinencemultimodal physiotherapy

Outcome Measures

Primary Outcomes (1)

  • Percent reduction in the number of urinary incontinence episodes

    The 7-day bladder diary was selected as the primary outcome to measure urinary leakage reduction

    baseline, post-treatment (3 months post-randomization) and 9 months after randomization

Secondary Outcomes (7)

  • Change in symptoms and impact of incontinence and other urogynecological conditions

    baseline, post-treatment (3 months post-randomization) and 9 months after randomization

  • Change in pelvic floor muscle morphometry and function

    baseline, post-treatment (3 months post-randomization) and 9 months after randomization

  • Change in severity of prolapse

    baseline, post-treatment (3 months post-randomization) and 9 months after randomization

  • Change in sexual function

    baseline, post-treatment (3 months post-randomization) and 9 months after randomization

  • Change in self-efficacy

    baseline, post-treatment (3 months post-randomization) and 9 months after randomization

  • +2 more secondary outcomes

Study Arms (2)

Multimodal physiotherapy

EXPERIMENTAL

12 weeks of weekly multimodal physiotherapy treatments

Procedure: Multimodal physiotherapy

Waiting-list control group

NO INTERVENTION

12 weeks of weekly full-body relaxation massage

Interventions

12 weeks of weekly physiotherapy treatments including education segment, electrical stimulation and PFM exercises consisting of strength, endurance and coordination exercises accompanied by biofeedback

Multimodal physiotherapy

Eligibility Criteria

Age18 Years - 45 Years
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • years old
  • Postpartum women (≥ 1 vaginal delivery at term (≥ 37 weeks) and ≥ 3 months postpartum
  • ≥ 3 urinary incontinence episodes per week over the last 3 months (Symptoms of incontinence must be associated predominantly or solely with stress urinary incontinence (as opposed to urge incontinence) which will be determined with a recommended and validated diagnosis questionnaire (Questionnaire for Urinary Incontinence Diagnosis))
  • Women with diagnosis avulsion injury

You may not qualify if:

  • Pregnancy or postmenopausal
  • Previous pelvic irradiation, urogynecological surgery, or PFM physiotherapy after the avulsion occurred
  • Significant prolapse (≥3 degree)
  • Incontinence due to other causes such as infection, neurological diseases, voiding difficulties
  • Any other acute or chronic medical problems likely to interfere with treatment or evaluation such as cancer, chronic constipation (Rome III criteria), obesity (body mass index \>35), pacemaker, bladder stimulator
  • Medication or ongoing treatment likely to interfere with incontinence

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Centre Hospitalier Universitaire de Sherbrooke

Sherbrooke, Quebec, J1H 5N4, Canada

Location

MeSH Terms

Conditions

Urinary IncontinenceFractures, Avulsion

Condition Hierarchy (Ancestors)

Urination DisordersUrologic DiseasesFemale Urogenital DiseasesFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesMale Urogenital DiseasesLower Urinary Tract SymptomsUrological ManifestationsSigns and SymptomsPathological Conditions, Signs and SymptomsFractures, BoneWounds and Injuries

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
QUADRUPLE
Who Masked
PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Researcher and Associate Professor

Study Record Dates

First Submitted

August 9, 2017

First Posted

August 18, 2017

Study Start

August 28, 2017

Primary Completion

May 10, 2023

Study Completion

May 10, 2023

Last Updated

June 15, 2023

Record last verified: 2023-06

Locations